Gilead’s Veklury shows ‘no antiviral effects,’ small WHO study says as company stands by COVID mednews2021-07-12T18:59:36+00:00July 12th, 2021|Fierce Pharma|
Johnson & Johnson’s COVID-19 shot hit again as feds plan to tag Guillain-Barré warning on label: reportsnews2021-07-12T18:30:29+00:00July 12th, 2021|Fierce Pharma|
With Takhzyro durability data, Takeda tries to fend off BioCryst’s hereditary angioedema challenger Orladeyonews2021-07-12T17:06:08+00:00July 12th, 2021|Fierce Pharma|
China’s Sinovac, Sinopharm ink COVAX supply deal for up to 550M coronavirus vaccine dosesnews2021-07-12T15:21:26+00:00July 12th, 2021|Fierce Pharma|
Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analystnews2021-07-12T14:29:02+00:00July 12th, 2021|Fierce Pharma|
With sweeping executive order, Biden puts drug pricing, anti-competitive strategies in the crosshairsnews2021-07-12T13:51:36+00:00July 12th, 2021|Fierce Pharma|
Pfizer to meet with FDA to discuss COVID-19 boosters, but will the U.S. get on board?news2021-07-12T13:36:42+00:00July 12th, 2021|Fierce Pharma|
Horizon teams up with Olympic champion to raise awareness around Graves’ disease and thyroid eye diseasenews2021-07-12T07:37:02+00:00July 12th, 2021|Fierce Pharma|
Sunovion takes Urovant’s overactive bladder med Gemtesa to primary care docs as promo partnership launchesnews2021-07-12T00:57:40+00:00July 12th, 2021|Fierce Pharma|
Seagen, Astellas’ Padcev snares full approval and expands into second-line treatment on path to blockbuster landnews2021-07-09T20:34:09+00:00July 9th, 2021|Fierce Pharma|
